What is Kyverna Therapeutics, Inc.'s return on equity?

Kyverna Therapeutics, Inc. (KYTX) reported return on equity of -74.5% in Q1 2026.

How has Kyverna Therapeutics, Inc.'s return on equity changed year-over-year?

Kyverna Therapeutics, Inc.'s return on equity decreased by 50.0% year-over-year, from -49.7% to -74.5%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Kyverna Therapeutics, Inc. KYTX Return on equity

Return on equity at other companies

Bristol-Myers SquibbBMY

38.8%+7.3pp

Gilead SciencesGILD

43.2%+10.7pp

Climb Bio, Inc.CLYM

-30.9%-10.3pp

Artiva Biotherapeutics, Inc.ARTV

-67.9%—

Iovance Biotherapeutics, Inc.IOVA

-47.5%-3.7pp

Viridian Therapeutics, Inc.VRDN

-58.1%+7.9pp

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

CapEx$2.0K-98.0%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Enterprise value$475.49M+475%

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Calculated from Kyverna Therapeutics, Inc.’s reported figures.

net income/total stockholders equity=-74.5%

Based on trailing twelve months.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s return on equity?: Kyverna Therapeutics, Inc. (KYTX) reported return on equity of -74.5% in Q1 2026.
How has Kyverna Therapeutics, Inc.'s return on equity changed year-over-year?: Kyverna Therapeutics, Inc.'s return on equity decreased by 50.0% year-over-year, from -49.7% to -74.5%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.